ClinicalTrials.gg
RecruitingNCT07950800FTTNUpdated Nov 20, 2026

From There Towards Now; Intervention for Jewish and Indonesian Post-war Generations

An interventional study of FTTN: From There Towards Now in Anxiety Disorders and Symptoms, Depressive Disorder and Personality Disorders, sponsored by Arkin. Recruiting at 2 sites in Netherlands. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Arkin · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 70 studies in Anxiety Disorders with a site in Netherlands — 19 open to participants now, 22 under way, none of them phase 3. Anxiety Disorders · Netherlands.

Planned enrollment
54th of 60
20 · median 156
Started
2025
with 5 others
No phase
52 of 70
18 open now
Primary completion
2027-08
later than 19 of 21 live
Registered
36th of 70
by date

Among the 70 studies in Anxiety Disorders with a site in Netherlands, this one is the 54th largest by planned enrollment of the 60 interventional ones that give a count, is one of 6 that started in 2025, is one of 52 with no phase, reaches primary completion later than 19 of the 21 other live ones, and was the 36th registered.

Anxiety Disorders

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

Browse Anxiety Disorders studies →

Open to participants now

19 of the 70 studies in Anxiety Disorders with a site in Netherlands are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Anxiety Disorders with a site in Netherlands, or all of them as a file.
02

Study summary

The goal of this open pilot study is to learn whether FTTN is effective in treating mental health problems in adult children of World War 2-survivors, who attribute their symptoms of anxiety, mood and/or personality problems to their parents' war trauma.

Participants will:

  • Participate in the FTNN intervention.
  • Answer questionnaires three times over five months: before starting FTTN, directly after completing FTTN, and two months after finishing FTTN.
  • Participate in an interview twice: before starting FTNN and directly after completing FTNN.
Read the detailed description

The Children of Parents with Mental Illnesss following Trauma, here called COPMI-T, often display anxiety, mood and personality symptoms, which they attribute to the trauma history of their parents. Guideline interventions for anxiety, mood and personality disorders often offer little room for addressing that specific context. Based on years of experience with the Jewish and Indonesian post-war generation of the Second World War, a new therapy method 'From There Towards Now' (FTTN or VDNN) was developed in the Sinai Center and applied to adult COPMI-T.

Brief description of FTTN:

1) the home situation with traumatized educators is concisely symbolized in an emotionally corrective setting with a therapist; 2) the parents have woven destructive conclusions from the context of their traumatization into the upbringing. This interferes with their children's healthy emotional development. In the therapy, these (now adult) KOPP-T children are helped to recognize, investigate and ultimately reject this transgenerational phenomenon in their upbringing; 3) the KOPP-T children are proposed to distance themselves from those parent-child relational codes that are associated with the traumatization of the parents; 4) KOPP-T children are encouraged to detach from the parents and to attach their own meanings to the traumatization of the parents. This promotes the construction of a healthy and meaningful existence.

The FTTN intervention consists of 4 individual sessions of 75 minutes during approximately 2 months, plus a follow-up session after 2 months with one family member. Dolls and time screens are used to symbolize the memories and to non-verbally express the process of separation.

The aim of this pilot study is to explore whether the intervention 'From There Towards Now' is effective in reducing anxiety and mood (OQ-45), obsessive-compulsive (Y-BOCS), PTSD (PCL- 5) and personality symptoms (SIPP-SF), next to quality of life (EQ-5D-5L), interpersonal functioning (RSQ/CPI), and the relationship with the war-affected parent(s) (measured with a qualitative interview). The study concerns an open pilot study, in which the effectiveness of FTNN is tested in COPMI-T, who are being treated or will be treated at the outpatient clinic of the Sinai Center.

The study has 3 measurement points (Baseline (T0): start of the intervention, 2 months later (T1): end of the intervention, and follow-up: 2 months after T1). The risk of this study has been assessed as 'negligible'. During the intervention there may be perceived emotional distress in the form of feelings of disappointment, anger and sadness. These are common in psychotherapy, and also necessary to accomplish change. Working with trained therapists and excluding specific vulnerable subgroups (e.g., ASD, psychosis, mental disability) from participation, ensures that participants' distress remains manageable and ultimately leads to a better emotional equilibrium. This estimate is based on experience with this method, which has been developed and described in the last 10 years.

03

Conditions studied

  • Anxiety Disorders and Symptoms
  • Depressive Disorder
  • Personality Disorders
  • Trauma, Psychological
  • Trauma and Stressor Related Disorders

Keywords

  • Anxiety Disorder
  • Depressive Disorders
  • Personality Disorder
  • Psychological Trauma
  • Post-Word War II generation
  • Intervention
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18+ children of one or two parents who have undergone WO-II trauma that have had a disruptive influence on their development; it is often unknown if these parent(s) met criteria for PTSD.
  2. Client seeks help because of fear, depression or personality complaints that they attribute to the war history of the parent(s).
  3. Client i) is on the waiting list for disorder-specific treatment or, ii) has residual symptoms despite a completed treatment guideline for a specific disorder.

Exclusion criteria

Exclusion Criteria:

  1. Psychotic Disorder
  2. Sever Major Depressive Disorder
  3. Severe Substance Use
  4. Autism spectrum Disorder
  5. Mental disability or illiteracy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Intervention FTTN

    Pre-post design

    Behavioral: FTTN: From There Towards Now

Interventions

  • BehavioralFTTN: From There Towards Now

    The FTTN intervention consists of 4 individual sessions of 75 minutes during approximately 2 months, plus a follow-up session after 2 months with one family member. Dolls and time screens are used to symbolize the memories and to non-verbally express the process of separation.

06

What researchers measure

Primary outcomes

  1. Change in Outcome Questionnaire-45 (OQ-45)

    General psychological symptoms, including anxiety and mood symptoms. Range: 0-180 Higher score = more severe symptoms ( = worse)

    Time frame: Baseline (T0), 2 months (T1), 4 months (T2)

Secondary outcomes

  1. Change in Yale-Brown Obsessive Compulsive Scale (Y-BOCS)

    Obsessive compulsive symptoms. Range = 0-50. Higher score = more severe symptoms ( = worse).

    Time frame: Baseline (T0), 2 months (T1), 4 months (T2)

  2. Change in PTSD Symptom checklist for the DSM-5 (PCL-5)

    PTSD symptoms. Range: 0-80. Higher score = more severe symptoms ( = worse).

    Time frame: Baseline (T0), 2 months (T1), 4 months (T2)

  3. Change in Severity Index of Personality Problems (SIPP-SF).

    Personality problems. Range: 0-240. Higher score = better functioning ( = better).

    Time frame: Baseline (T0), 2 months (T1), 4 months (T2)

  4. Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L)

    Quality of life. Range: 5-25. Higher scores = more severe problems and/or problems on more different life domains ( = worse).

    Time frame: Baseline (T0), 2 months (T1), 4 months (T2)

  5. Change in CPI (Close Person Inventory)

    Interpersonal functioning. Range: 10-50 per subscale. Higher scores = more social support ( = better) (some items will be recoded because they are reversed: higher score = less support).

    Time frame: Baseline (T0), 2 months (T1), 4 months (T2).

  6. Change in Relationship Scale Questionnaire (RSQ)

    Attachment. Range: 15-75 per dimension (Model of Self and Model of Other). Higher scores on each dimension = More secure ( = better) (some items will be recoded because they are reversed: higher score = less secure).

    Time frame: Baseline (T0), 2 months (T1), 4 months (T2).

  7. Change in insight into illness/attribution and relationship with parents

    Qualitative interview

    Time frame: Baseline (T0) and 4 months (T2)

Other outcomes

  1. Childhood Trauma Questionnaire (CTQ)

    Childhood Trauma. Range: 5-25 per subscale (emotional abuse, physical abuse, sexual abuse, emotional neglect, physical neglect). Higher score = more severe childhood trauma ( = worse).

    Time frame: Baseline (T0)

  2. Life Events Questionnaire for DSM-5 (LEC-5)

    Life Events. Range = LEC-5 contains 17 events, but participants may report more than one type of exposure to each event (e.g., experienced personally and witnessed it happening to someone else). Higher score = more life events (does not measure severity/intensity).

    Time frame: Baseline (T0)

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Jacobs, F. (2017). Van daar naar nu. Beter contact tussen geweldslachtoffers en naasten. Totemboek
  • Jacobs, F. (2012). Pijnlijke verrijking. Rouw en herboren relaties in de slagschaduw van oorlogsgeweld. Totemboek

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Aug 2027, 28 months after the start.

Of 105 industry-sponsored interventional studies with no phase under Anxiety Disorders, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 16. This study's planned 28 months is above that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 8, 2022
First posted
Nov 20, 2026
StartActual
Apr 1, 2025
Primary completionEst.
Aug 1, 2027
CompletionEst.
Dec 1, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07950800
Lead sponsor
Arkin
Responsible party
Sponsor
First posted
Nov 20, 2026
Start date
Apr 1, 2025
Primary completion
Aug 1, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Nov 20, 2026

Study contacts

Kathleen Thomaes
Contact
k.thomaes@sinaicentrum.nl
0205457200
Ellen Vedel
Contact
e.vedel@sinaicentrum.nl
Ellen Vedel
study chair · Sinai Centrum / Arkin

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion